Compare IRTC & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | WFRD |
|---|---|---|
| Founded | 2006 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 6.0B |
| IPO Year | 2016 | 2014 |
| Metric | IRTC | WFRD |
|---|---|---|
| Price | $113.00 | $86.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $207.54 | $97.50 |
| AVG Volume (30 Days) | 639.6K | ★ 1.2M |
| Earning Date | 05-25-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 5.93 |
| Revenue | $747,138,000.00 | ★ $4,331,000,000.00 |
| Revenue This Year | $19.58 | $0.37 |
| Revenue Next Year | $15.95 | $3.48 |
| P/E Ratio | ★ N/A | $14.35 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $92.52 | $36.74 |
| 52 Week High | $210.01 | $110.57 |
| Indicator | IRTC | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 24.93 | 34.08 |
| Support Level | N/A | $82.22 |
| Resistance Level | $161.36 | $91.23 |
| Average True Range (ATR) | 5.80 | 4.13 |
| MACD | -1.26 | -2.18 |
| Stochastic Oscillator | 2.48 | 9.67 |
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.